4408 related articles for article (PubMed ID: 24336571)
21. Repurposing CRISPR/Cas9 for in situ functional assays.
Malina A; Mills JR; Cencic R; Yan Y; Fraser J; Schippers LM; Paquet M; Dostie J; Pelletier J
Genes Dev; 2013 Dec; 27(23):2602-14. PubMed ID: 24298059
[TBL] [Abstract][Full Text] [Related]
22. Genome-wide CRISPR screening reveals genetic modifiers of mutant EGFR dependence in human NSCLC.
Zeng H; Castillo-Cabrera J; Manser M; Lu B; Yang Z; Strande V; Begue D; Zamponi R; Qiu S; Sigoillot F; Wang Q; Lindeman A; Reece-Hoyes JS; Russ C; Bonenfant D; Jiang X; Wang Y; Cong F
Elife; 2019 Nov; 8():. PubMed ID: 31741433
[TBL] [Abstract][Full Text] [Related]
23. Targeted mutagenesis of aryl hydrocarbon receptor 2a and 2b genes in Atlantic killifish (Fundulus heteroclitus).
Aluru N; Karchner SI; Franks DG; Nacci D; Champlin D; Hahn ME
Aquat Toxicol; 2015 Jan; 158():192-201. PubMed ID: 25481785
[TBL] [Abstract][Full Text] [Related]
24. Genome-scale deletion screening of human long non-coding RNAs using a paired-guide RNA CRISPR-Cas9 library.
Zhu S; Li W; Liu J; Chen CH; Liao Q; Xu P; Xu H; Xiao T; Cao Z; Peng J; Yuan P; Brown M; Liu XS; Wei W
Nat Biotechnol; 2016 Dec; 34(12):1279-1286. PubMed ID: 27798563
[TBL] [Abstract][Full Text] [Related]
25. Dual direction CRISPR transcriptional regulation screening uncovers gene networks driving drug resistance.
le Sage C; Lawo S; Panicker P; Scales TME; Rahman SA; Little AS; McCarthy NJ; Moore JD; Cross BCS
Sci Rep; 2017 Dec; 7(1):17693. PubMed ID: 29255251
[TBL] [Abstract][Full Text] [Related]
26. A Flexible, Pooled CRISPR Library for Drug Development Screens.
Blanck M; Budnik-Zawilska MB; Lenger SR; McGonigle JE; Martin GRA; le Sage C; Lawo S; Pemberton HN; Tiwana GS; Sorrell DA; Cross BCS
CRISPR J; 2020 Jun; 3(3):211-222. PubMed ID: 33054419
[TBL] [Abstract][Full Text] [Related]
27. RNAi/CRISPR Screens: from a Pool to a Valid Hit.
Schuster A; Erasimus H; Fritah S; Nazarov PV; van Dyck E; Niclou SP; Golebiewska A
Trends Biotechnol; 2019 Jan; 37(1):38-55. PubMed ID: 30177380
[TBL] [Abstract][Full Text] [Related]
28. A High-Resolution Genome-Wide CRISPR/Cas9 Viability Screen Reveals Structural Features and Contextual Diversity of the Human Cell-Essential Proteome.
Bertomeu T; Coulombe-Huntington J; Chatr-Aryamontri A; Bourdages KG; Coyaud E; Raught B; Xia Y; Tyers M
Mol Cell Biol; 2018 Jan; 38(1):. PubMed ID: 29038160
[TBL] [Abstract][Full Text] [Related]
29. CRISPR knockout screening outperforms shRNA and CRISPRi in identifying essential genes.
Evers B; Jastrzebski K; Heijmans JP; Grernrum W; Beijersbergen RL; Bernards R
Nat Biotechnol; 2016 Jun; 34(6):631-3. PubMed ID: 27111720
[TBL] [Abstract][Full Text] [Related]
30. Design and Validation of CRISPR/Cas9 Systems for Targeted Gene Modification in Induced Pluripotent Stem Cells.
Lee CM; Zhu H; Davis TH; Deshmukh H; Bao G
Methods Mol Biol; 2017; 1498():3-21. PubMed ID: 27709565
[TBL] [Abstract][Full Text] [Related]
31. Genome-Scale CRISPRa Screen Identifies Novel Factors for Cellular Reprogramming.
Yang J; Rajan SS; Friedrich MJ; Lan G; Zou X; Ponstingl H; Garyfallos DA; Liu P; Bradley A; Metzakopian E
Stem Cell Reports; 2019 Apr; 12(4):757-771. PubMed ID: 30905739
[TBL] [Abstract][Full Text] [Related]
32. Production of genome-edited pluripotent stem cells and mice by CRISPR/Cas.
Horii T; Hatada I
Endocr J; 2016; 63(3):213-9. PubMed ID: 26743444
[TBL] [Abstract][Full Text] [Related]
33. A Genome-Editing Nanomachine Constructed with a Clustered Regularly Interspaced Short Palindromic Repeats System and Activated by Near-Infrared Illumination.
Peng H; Le C; Wu J; Li XF; Zhang H; Le XC
ACS Nano; 2020 Mar; 14(3):2817-2826. PubMed ID: 32048826
[TBL] [Abstract][Full Text] [Related]
34. Genome-Wide CRISPR Screen Identifies Host Factors Required by
Wu SZ; Wei HX; Jiang D; Li SM; Zou WH; Peng HJ
Front Cell Infect Microbiol; 2019; 9():460. PubMed ID: 32039045
[No Abstract] [Full Text] [Related]
35. [Advances in application of clustered regularly interspaced short palindromic repeats (CRISPR)/CRISPR-associated 9 system in stem cells research].
Sun SJ; Huo JH; Geng ZJ; Sun XY; Fu XB
Zhonghua Shao Shang Za Zhi; 2018 Apr; 34(4):253-256. PubMed ID: 29690746
[TBL] [Abstract][Full Text] [Related]
36. Functional Screening of Candidate Causal Genes for Insulin Resistance in Human Preadipocytes and Adipocytes.
Chen Z; Yu H; Shi X; Warren CR; Lotta LA; Friesen M; Meissner TB; Langenberg C; Wabitsch M; Wareham N; Benson MD; Gerszten RE; Cowan CA
Circ Res; 2020 Jan; 126(3):330-346. PubMed ID: 31739742
[No Abstract] [Full Text] [Related]
37. Silencing FLI or targeting CD13/ANPEP lead to dephosphorylation of EPHA2, a mediator of BRAF inhibitor resistance, and induce growth arrest or apoptosis in melanoma cells.
Azimi A; Tuominen R; Costa Svedman F; Caramuta S; Pernemalm M; Frostvik Stolt M; Kanter L; Kharaziha P; Lehtiö J; Hertzman Johansson C; Höiom V; Hansson J; Egyhazi Brage S
Cell Death Dis; 2017 Aug; 8(8):e3029. PubMed ID: 29048432
[TBL] [Abstract][Full Text] [Related]
38. Genome-wide CRISPR Screens in Primary Human T Cells Reveal Key Regulators of Immune Function.
Shifrut E; Carnevale J; Tobin V; Roth TL; Woo JM; Bui CT; Li PJ; Diolaiti ME; Ashworth A; Marson A
Cell; 2018 Dec; 175(7):1958-1971.e15. PubMed ID: 30449619
[TBL] [Abstract][Full Text] [Related]
39. Simultaneous Knockout of CXCR4 and CCR5 Genes in CD4+ T Cells via CRISPR/Cas9 Confers Resistance to Both X4- and R5-Tropic Human Immunodeficiency Virus Type 1 Infection.
Yu S; Yao Y; Xiao H; Li J; Liu Q; Yang Y; Adah D; Lu J; Zhao S; Qin L; Chen X
Hum Gene Ther; 2018 Jan; 29(1):51-67. PubMed ID: 28599597
[TBL] [Abstract][Full Text] [Related]
40. Protein stability regulators screening assay (Pro-SRSA): protein degradation meets the CRISPR-Cas9 library.
Wu Y; Kang T
Chin J Cancer; 2016 Jun; 35(1):60. PubMed ID: 27357860
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
